![](/img/cover-not-exists.png)
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
Masashi Shiomi, Takashi Ito, Toyohiro Tsukada, Yoshio Tsujita, Hiroyoshi HorikoshiVolume:
142
Year:
1999
Language:
english
DOI:
10.1016/s0021-9150(98)00259-7
File:
PDF, 165 KB
english, 1999